Skip to main content
    R

    Recursion Pharmaceuticals Inc (RXRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.72
    -0.18 (-6.37%)

    Market Cap: $1.99B

    Last updated: Nov 17, 2026 at 4:44 PM ET

    Recursion Pharmaceuticals Inc (RXRX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Recursion Pharmaceuticals (RXRX) has a latest price of $2.72 on Nov 17, 2026. Its price fell 34.3% over the past 12 months. The month-end price fell 79.0% over the 5 years through Oct 2026, a compound annual decline of 26.8%.

    Price Chart

    From Apr 2021 to Oct 2026, its highest month-end close was $36.50 in Jun 2021 and its lowest $3.00 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RXRX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RXRX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 22.3%, and over 6 months it fell 4.6%. The month-end price fell 23.7% over the 3 years through Oct 2026, a compound annual decline of 8.6%.

    PeriodChange
    1 month-24.7%
    3 months-22.3%
    6 months-4.6%
    12 months-34.3%
    12 months, with dividends-34.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-23.7%-8.6%
    5 years-79.0%-26.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 27.9%, and its weakest was 2022, when it fell 55.0%.

    YearCloseChange
    2026 through Oct 2026$4.03-1.5%
    2025$4.09-39.5%
    2024$6.76-31.4%
    2023$9.86+27.9%
    2022$7.71-55.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 27.5% below its 50-day average of $3.75 and 21.4% below its 200-day average of $3.46.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.72
    50-day average$3.75-27.5%
    200-day average$3.46-21.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 82.5%.

    MeasureValue
    1-year beta2.94
    Largest fall, 1 year-45.2%
    Largest fall, 3 years-82.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RXRX

    What is RXRX's 1-year price change?

    Recursion Pharmaceuticals's price fell 34.3% over the past 12 months. With dividends included, the 12-month total return was -34.3%.

    What is RXRX's 5-year price change?

    Recursion Pharmaceuticals's month-end price fell 79.0% over the 5 years through Oct 2026, a compound annual decline of 26.8%. These figures leave out dividends.

    What is RXRX's beta?

    Recursion Pharmaceuticals's 1-year beta against the S&P 500 is 2.94, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 45.2%.

    Is the RXRX chart free?

    Yes. Advanced Charting for RXRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.